Dem senators ask drug companies to list prices in ads

Dem senators ask drug companies to list prices in ads
© Getty Images

A group of mostly Democratic senators is urging eight major drug companies to include the price of their drugs in advertisements, a measure that President TrumpDonald TrumpBiden heading to Kansas City to promote infrastructure package Trump calls Milley a 'f---ing idiot' over Afghanistan withdrawal First rally for far-right French candidate Zemmour prompts protests, violence MORE endorsed last week in his drug-pricing blueprint.

“We are pleased that the President recently acknowledged the importance of requiring price disclosure on direct-to-consumer ads—it is our hope that he will actually follow through,” Sens. Dick DurbinDick DurbinFour questions that deserve answers at the Guantanamo oversight hearing Senate dodges initial December crisis with last-minute deal Conservatives target Biden pick for New York district court MORE (D-Ill.), Kirsten GillibrandKirsten GillibrandEx-officials voice deep concerns over new Pentagon UFO unit Paid leave advocates ramping up the pressure on Manchin and Schumer Gillibrand, bipartisan lawmakers push to keep military justice overhaul in NDAA MORE (D-N.Y.), Maggie HassanMargaret (Maggie) HassanConservative group targeting Kelly, Hassan, Cortez Masto in multi-million-dollar ad blitz Biden signs four bills aimed at helping veterans Constant threats to government funding fail the American public MORE (D-N.H.), Sherrod BrownSherrod Campbell BrownSenate race in Ohio poses crucial test for Democrats Powell says Fed will consider faster taper amid surging inflation Biden faces new pressure from climate groups after Powell pick MORE (D-Ohio) and Angus KingAngus KingAmazon, Facebook, other large firms would pay more under proposed minimum tax, Warren's office says Senators look to defense bill to move cybersecurity measures Energy information chief blames market for high fuel prices MORE (I-Maine) wrote to the drug companies.

“As an honest first step to the American public, we urge you to immediately and voluntarily commit to transparency and disclose the price of your prescription drugs in direct-to-consumer advertisements,” the letter sent Friday states.

ADVERTISEMENT

The letter was sent to major pharmaceutical companies such as Eli Lilly, Novartis and Pfizer. 

Trump released a plan last week directing the Food and Drug Administration to study the possibility of including the list prices of drugs in direct-to-consumer advertising. The measure was part of Trump's blueprint aimed at lowering prescription drug costs.

Durbin introduced a bill last year that would require a similar disclosure of drug prices.

While pharmaceutical companies have to include warnings and side effects for drugs in television advertisements, they currently do not have to include prices.

Some have voiced concerns that including the list price of drugs could confuse consumers or deter them from purchasing the product, since the price at a pharmacy is often much lower if the individual has health insurance.

At an event with reporters Tuesday, Lori Reilly, an executive vice president of the Pharmaceutical Research and Manufacturers of America (PhRMA), discussed the issue of forcing companies to include the price of drugs in ads, arguing "it’s an open question about whether or not it’s constitutional.”

This post was updated at 4 p.m.